↓ Skip to main content

Stüve-Wiedemann syndrome: LIFR and associated cytokines in clinical course and etiology

Overview of attention for article published in Orphanet Journal of Rare Diseases, March 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
59 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Stüve-Wiedemann syndrome: LIFR and associated cytokines in clinical course and etiology
Published in
Orphanet Journal of Rare Diseases, March 2014
DOI 10.1186/1750-1172-9-34
Pubmed ID
Authors

Dawn Mikelonis, Cheryl L Jorcyk, Ken Tawara, Julia Thom Oxford

Abstract

Stüve-Wiedemann syndrome (STWS; OMIM #610559) is a rare bent-bone dysplasia that includes radiologic bone anomalies, respiratory distress, feeding difficulties, and hyperthermic episodes. STWS usually results in infant mortality, yet some STWS patients survive into and, in some cases, beyond adolescence. STWS is caused by a mutation in the leukemia inhibitory factor receptor (LIFR) gene, which is inherited in an autosomally recessive pattern. Most LIFR mutations resulting in STWS are null mutations which cause instability of the mRNA and prevent the formation of LIFR, impairing the signaling pathway. LIFR signaling usually follows the JAK/STAT3 pathway, and is initiated by several interleukin-6-type cytokines. STWS is managed on a symptomatic basis since there is no treatment currently available.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Haiti 1 2%
Peru 1 2%
Unknown 57 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 11 19%
Student > Bachelor 7 12%
Student > Master 6 10%
Other 5 8%
Student > Postgraduate 5 8%
Other 15 25%
Unknown 10 17%
Readers by discipline Count As %
Medicine and Dentistry 17 29%
Agricultural and Biological Sciences 13 22%
Biochemistry, Genetics and Molecular Biology 8 14%
Business, Management and Accounting 2 3%
Computer Science 2 3%
Other 3 5%
Unknown 14 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 September 2019.
All research outputs
#10,235,660
of 16,614,363 outputs
Outputs from Orphanet Journal of Rare Diseases
#1,153
of 1,764 outputs
Outputs of similar age
#99,405
of 191,734 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#19
of 31 outputs
Altmetric has tracked 16,614,363 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,764 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 191,734 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.